How Long After Extraction Can You Smoke?

Reviewed 2 September 2026. Twenty-six records, each pulled and re-checked against Europe PMC before publication: three systematic reviews and one meta-analysis of clinical trials, one umbrella review of 69 systematic reviews, three scoping reviews, five cross-sectional or register studies, one case series and several narrative reviews, plus the implant-risk synthesis and two animal studies used only where the article says so. Every number below is printed in the abstract of the record cited beside it. This article exists because the advice patients actually receive is a round number, and the trials that exist do not contain that number. Not medical advice; the questions to ask your own clinician are in the plan section.

The short answers

• Smoking after extraction is a measured risk, not folklore. In an audit of consecutive extractions at a tertiary dental hospital, the overall post-extraction complication rate was 11.0%, the two commonest problems being persistent post-operative pain (4.1%) and alveolar osteitis (3.4%), and the statistically significant patient-related risk factors were smoking, uncontrolled diabetes and hypertension; surgical extractions, mandibular teeth, student operators and general anaesthesia also raised risk (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643). Note the shape of that finding: smoking appears on the same list as uncontrolled diabetes, not as a footnote.
• There is no trial that validates “wait 48 hours”. The evidence base contains no randomised comparison of 24 versus 48 versus 72 hours of abstinence after extraction; what exists is the observational risk data above, mechanism, and a broader surgical literature showing that nicotine dependence is associated with more complications. The clinic’s number is a risk-reduction target, and the honest framing is: the first days are when the clot and the granulation tissue are most fragile, and every hour you do not smoke in that window moves you toward the lower end of a real, quantified risk (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902).
• “I covered it with gauze” is not in any study. The most-asked follow-up question in English-language search results — smoking after extraction if the socket is covered with gauze — has no trial behind it. What is documented is that the mechanism is not only suction: nicotine is a vasoconstrictor, smoke carries carbon monoxide, and the heat and chemistry act on the wound; in vitro work on oral fibroblasts found flavouring aldehydes such as cinnamaldehyde and vanillin raising intracellular reactive oxygen species, driving protein carbonylation, interleukin-8 and prostaglandin E2 secretion and increasing apoptosis (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527). A physical barrier does not change vasoconstriction.
• Vaping is not neutral for the mouth. In a pilot cross-sectional study, every vaper had low resting salivary flow, with low buffering capacity in 36.8% versus 1.2% of non-smokers and acidic saliva in 92.9% versus 7.1% (p = 0.000 in both) (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418). A systematic review of periodontal outcomes in 13 studies found cigarette smokers worse than vapers and non-smokers on gingival and plaque indices, probing depth beyond 3 mm and attachment loss, while noting vaping still needs examination (Aldalaeen et al., Health Sci Rep 2025-09-01, PMID 40959186); a review of 12 molecular microbiota studies found distinct oral communities in e-cigarette users with enrichment of Veillonella, Leptotrichia and Fusobacterium versus never smokers — certainty graded very low (La Rosa et al., J Clin Periodontol 2026-06-01, PMID 41856754). A scoping review of ages 12 to 24 reported associations with caries, dry mouth, gingival conditions, oral lesions and fractured teeth, and noted that young users’ knowledge of these effects was low (Tran et al., Int J Paediatr Dent 2026-07-01, PMID 41992606).
• Nicotine itself is the part with the least evidence and the most relevance to sockets and bone. A systematic review of 62 studies on non-tobacco nicotine and bone healing found delayed healing, reduced new bone formation, more necrosis and slowed osseointegration with higher doses inhibiting osteoblast proliferation — and, at low doses, some anti-inflammatory offset — while stating plainly that human studies isolating nicotine from tobacco and aerosol are missing (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042). In the largest transferable dataset here, nicotine dependence recorded in the six months before surgery was analysed in 56,992 propensity-matched breast reconstruction pairs and raised seroma (RR 1.224, 95% CI 1.177 to 1.274) as well as capsular contracture and implant-related mechanical complications (Tanas et al., Plast Reconstr Surg Glob Open 2026-05-01, PMID 42145836).
• Cannabis has a specific, under-discussed problem: anaesthesia. A 2026 case report describes a 34-year-old chronic cannabis user with a hyperalgesic pain response and difficulty achieving adequate local anaesthesia during extraction despite standard techniques, attributed to cannabis-related changes in pain pathways and pharmacokinetics (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491). The systematic evidence on cannabinoids for orofacial pain is thin: five studies, one showing a significant effect for topical cannabidiol in temporomandibular disorder pain and four showing none, with the authors concluding there is insufficient evidence for a tangible clinical benefit (Votrubec et al., Aust Dent J 2022-12-01, PMID 36082517); a later review found four randomised trials (three with low risk of bias) and nine animal studies, all nine at high risk of bias, with mixed results against standard treatment such as NSAIDs and corticosteroids (Campana et al., Int J Mol Sci 2025-04-01, PMID 40332414).
• What has been shown to help after extraction does not depend on your willpower. Chlorhexidine reduces alveolar osteitis risk (12-study analysis: 9.58% versus 16.8% control), platelet-rich fibrin in the socket reduced it with a risk ratio of 0.33 in seven trials covering 776 sites, and traditional NSAIDs do not raise alveolar osteitis risk while the COX-2 inhibitor rofecoxib did (OR 1.89, 95% CI 1.15 to 3.10; n = 947; I² = 0%) (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Ávila-Oliver et al., Med Oral Patol Oral Cir Bucal 2025-05-01, PMID 40121674) (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912). Compliance itself is modifiable: in a systematic review of 10 studies on how instructions are delivered, phone-call follow-up produced higher adherence scores (9.7 ± 0.5 and 9.14 ± 0.78) than extended written instructions (7.9 ± 2.1) (Fawzy et al., Clin Cosmet Investig Dent 2026-01-01, PMID 42222518).

What a cigarette does to a healing socket

Four separable mechanisms explain why clinicians bother, and why the advice is not only about the suction.

Vasoconstriction. Nicotine is a systemic vasoconstrictor, so the microcirculation feeding the clot and the newly forming granulation tissue is narrowed; the implant literature treats this as the operative pathway and concludes smoking is not an absolute contraindication but has a detrimental effect on peri-implant tissues, with a systematic review of 45 articles (44 studies, follow-up 1 to 17 years) finding a significantly reduced survival in cigarette smokers at both implant and patient level (OR 0.40, 95% CI 0.27 to 0.61) (Elena et al., Clin Oral Implants Res 2026-03-01, PMID 41776304). Oxygen delivery. Smoke raises carboxyhaemoglobin and, in the comparative study of young men who smoked cigarettes or hookah, both groups showed significantly increased red cell count, haemoglobin and haematocrit — the haematological signature of chronic hypoxic stress — alongside an oral bacterial load of 5.96 ± 0.19 log₁₀ CFU/mL in cigarette smokers against 3.70 ± 0.10 in non-smokers (Alghofaili et al., FASEB Bioadv 2026-06-01, PMID 42266505). Cellular toxicity. Beyond nicotine, the aerosol’s flavour aldehydes produced oxidative injury, IL-8 and PGE2 release and apoptosis in oral fibroblasts, the cells that rebuild the wound matrix (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527). Saliva. Vaping is associated with lower flow, lower buffering capacity and lower pH (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418) — the fluid that clears bacteria and buffers acid after a clot is gone.

Read together, this is why “it was only one puff” is the wrong frame: the risk is not a mechanical lottery in which you either dislodge the clot or you do not, it is a dose-dependent reduction in the perfusion and cellular machinery the socket needs, beginning within minutes of the first exposure.

Vaping, heated tobacco and hookah: what is actually known

The device-specific evidence in the mouth is thin but not empty, and the honest summary is that vaping looks less harmful than burning while still being measurably different from not using anything.

• Periodontium. A systematic review of 13 studies concluded cigarette smokers had worse periodontal conditions than both vapers and never-smokers — higher gingival index, poorer plaque index, lower bleeding on probing, mean probing depth above 3 mm and greater clinical attachment loss — with vaping’s effect described as lower but in need of further examination (Aldalaeen et al., Health Sci Rep 2025-09-01, PMID 40959186). A British Dental Journal narrative review reaches the same caution: some studies show worsened periodontal health and poorer response to periodontal treatment in e-cigarette users, evidence is mixed and high-quality work is scarce, and current research suggests e-cigarettes are safer for the periodontium than conventional smoking, though long-term cohorts are needed (Robson et al., Br Dent J 2025-11-01, PMID 41315696).
• Scale of exposure. About 100 million adults and 15 million adolescents use e-cigarettes; as of 2025 the WHO counted 88 countries without a minimum-age restriction and 74 with no regulation at all. The same review lists, in the mouth, high caries risk, greater staining of teeth and restorations, higher incidence of dry mouth, gingival inflammation and greater prevalence of periodontal and peri-implant disease versus non-users, plus nicotine stomatitis, hairy tongue and angular cheilitis more often than in former smokers — while also noting the high-certainty evidence that e-cigarettes help people quit, with four additional quitters per 100 (Kumar et al., Int Dent J 2026-06-01, PMID 41932095).
• Whole-body risk, quantified. An umbrella review of 69 systematic reviews (from 5 055 records) found increased heart rate (MD 1.41, 95% CI 0.81 to 2.01, I² = 91%), higher systolic blood pressure (MD 0.51 mm Hg, 0.26 to 0.75, I² = 89%) and diastolic (0.59, 0.35 to 0.83, I² = 82%), endothelial dysfunction, increased platelet activity and higher asthma incidence (OR 1.30, 1.1 to 1.55, I² = 43%) — small effects with high heterogeneity, and mental-health signals among adolescent users (Kaur et al., BMJ Open 2025-10-01, PMID 41073111).
• Hookah. The comparative study above found both cigarette and waterpipe use disrupted oral microbial balance, with cigarette smokers having the highest bacterial load; the correlation of dysbiosis with blood indices was strong (r = 0.91 to 0.94) but the authors explicitly describe it as parallel systemic effects of toxicants rather than a causal link (Alghofaili et al., FASEB Bioadv 2026-06-01, PMID 42266505). For socket healing specifically there is no hookah trial — the relevant fact is that waterpipe smoke still delivers combustion products, heat and nicotine through the same mouth that is bleeding.

Nicotine pouches, snus and the “at least it’s not smoke” argument

Patients increasingly ask about pouches because they can be used where smoking cannot. Two findings should be read together. First, pouches are not tissue-neutral: in a cross-sectional study of 126 nicotine-pouch users, 63 users of tobacco-derived pouches and 83 non-users, oral lesions were found in 79% of nicotine-pouch users and 89% of tobacco-pouch users, with erythema and symptoms more frequent in the nicotine-pouch group and hyperkeratosis predominating in the tobacco group, and a non-significant trend toward worse lesions with mint flavouring; no increased caries or periodontal risk was seen with up to six years of use (Daneshian et al., Oral Dis 2026-07-01, PMID 42384425). A systematic review of Swedish smokeless tobacco (26 studies of 2 176) found associations with gingival recession, especially with loose snus, more gingivitis independent of plaque, no significant association with periodontitis, inconsistent caries findings, plus tooth wear and self-reported temporomandibular symptoms — and a 48% higher risk of oral cleft malformations in offspring of mothers using snus in pregnancy (Bankvall et al., Acta Odontol Scand 2026-02-01, PMID 41649495).

Second, the harm-reduction case is real but unfinished: pouches show significantly lower harmful-constituent levels than cigarettes and traditional smokeless tobacco, and short-term clinical studies report reduced mucosal irritation and gingival inflammation in exclusive users, but no long-term epidemiological evidence exists on oral carcinogenesis and the available human studies are few, small and heterogeneous (La Rosa et al., Front Oral Health 2026-01-01, PMID 41737135). Where the socket is concerned, the relevant question is not carcinogenicity but perfusion and bone biology — and there the animal and in vitro synthesis shows nicotine itself slowing bone healing in a dose-dependent way, with the caveat that human isolation studies do not exist (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042). Placing a pouch against the gum next to a fresh extraction is the worst version of this option: it delivers the vasoconstrictor locally, at high concentration, onto a wound.

Cannabis: the anaesthesia problem nobody screens for

The dental literature on cannabis is small and mostly non-experimental, which is exactly why it should be read carefully rather than quoted either way. A systematic review of cannabinoid drugs and oral health reviewed the receptors in oropharyngeal tissue and the putative associations with oral disease, and argued for recording cannabis use in the dental record as a matter of good practice (Bellocchio et al., Int J Mol Sci 2021-08-01, PMID 34361095). For pain, the review of five studies found one positive result (topical cannabidiol in temporomandibular disorder) against four nulls, concluding that evidence is insufficient for a tangible clinical benefit (Votrubec et al., Aust Dent J 2022-12-01, PMID 36082517); a later systematic review found four randomised trials, three at low risk of bias, and nine animal studies, all at high risk of bias, with CBD sometimes reducing dental or myofascial pain and sometimes no better than NSAIDs or corticosteroids (Campana et al., Int J Mol Sci 2025-04-01, PMID 40332414).

The practical, extraction-specific signal is the anaesthesia and hyperalgesia report: chronic use was associated with difficulty achieving adequate block and an amplified pain response during extraction, and the authors’ recommendation is that clinicians ask about cannabis when planning anaesthesia and adapt the technique rather than treat it as noise (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491). If you are a regular user, the useful action is therefore not deciding whether to use before the appointment — it is telling the operator beforehand, because dosing, technique and the post-operative analgesic plan can all be adjusted in advance, and a failed block in a chair with a swelling face is a long afternoon (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491) (Kumar et al., Int Dent J 2026-06-01, PMID 41932095).

The numbers borrowed from other operations, and their limits

Dentistry has few trials of smoking timing, so clinicians reason from surgical fields that do. A scoping review of wound healing after facial procedures found nine of 129 screened studies met criteria, and active smoking was consistently associated with impaired healing with complication risks reported between 1.8-fold and 12-fold higher (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902). The largest single dataset here is a propensity-matched network analysis: 56,992 breast-reconstruction cases paired into two cohorts of 28,496, where documented nicotine dependence within six months before surgery raised seroma (RR 1.224, 95% CI 1.177 to 1.274) and also capsular contracture and implant-related mechanical complications, while lymphedema and flap loss did not differ significantly (Tanas et al., Plast Reconstr Surg Glob Open 2026-05-01, PMID 42145836). A systematic review of 62 studies on non-tobacco nicotine and bone healing supplies the mechanism, and the same authors flag the gap: no human studies isolate nicotine from smoke or aerosol (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042).

Say plainly what these are and are not. They are not extraction studies. A jaw socket is not a breast pocket, and the risk multipliers cannot be quoted to a patient as if they measured dry socket. What they do establish is that the direction and the size of the effect on wound healing are not marginal in any surgical field measured, which is why dentists treat this as worth an instruction rather than a shrug (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902) (Tanas et al., Plast Reconstr Surg Glob Open 2026-05-01, PMID 42145836).

What measurably reduces the risk

• Chlorhexidine at the socket. In the 12-study analysis of third-molar surgery, alveolar osteitis fell from 16.8% to 9.58% (a 42.9% relative reduction, p < 0.0001), in protocols without systemic antibiotics — so this is local antiseptic versus nothing, not versus antibiotics (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739). A separate scoping review covers its wider use in oral wound healing (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739).
• Biological dressing when the socket is large. Platelet-rich fibrin placed in the socket reduced alveolar osteitis with a risk ratio of 0.33 (95% CI 0.20 to 0.53) across seven randomised trials covering 776 sites (Ávila-Oliver et al., Med Oral Patol Oral Cir Bucal 2025-05-01, PMID 40121674).
• Pick the right painkiller. Traditional NSAIDs did not increase alveolar osteitis risk across 19 trials (n = 2 888); the selective COX-2 inhibitor rofecoxib did (OR 1.89, 95% CI 1.15 to 3.10; n = 947; I² = 0%) in 13 trials, with sensitivity analysis showing a robust signal (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912).
• Ask who follows up with you. Where instructions were reinforced by a phone call, adherence scores were higher (9.7 ± 0.5; 9.14 ± 0.78) than with extended written instructions alone (7.9 ± 2.1) (Fawzy et al., Clin Cosmet Investig Dent 2026-01-01, PMID 42222518).
• Adjuncts in compromised healing are plausible, not proven. A single case of socket preservation in a 51-year-old smoker with type 2 diabetes used an oxygen-releasing gel with the graft, healed uneventfully, and accepted an implant at six months — the authors call for properly powered randomised work (Aldulaijan et al., J Oral Implantol 2025-12-01, PMID 41365335).
• Reduction or pause, framed by the peri-operative evidence. The implant synthesis recommends integrating behavioural cessation counselling into the treatment plan for smokers rather than refusing implant therapy (Elena et al., Clin Oral Implants Res 2026-03-01, PMID 41776304); and where e-cigarettes are used to leave cigarettes, the reviews describe that as a documented benefit (four extra quitters per 100) alongside oral effects that still need managing (Kumar et al., Int Dent J 2026-06-01, PMID 41932095) (Robson et al., Br Dent J 2025-11-01, PMID 41315696).

How to read this like a clinician

• Ask about nicotine form, not smoking status: cigarettes, vapes, heated sticks, pouches, snus and cannabis all have different local effects on the same wound, and the pouch placed beside the socket is a different exposure from a patch on the arm (Daneshian et al., Oral Dis 2026-07-01, PMID 42384425) (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042).
• Record the specific numbers you can defend: alveolar osteitis 3.4% and total complications 11.0% with smoking among the significant patient-level risk factors in a tertiary audit — not a generic “smoking impairs healing” (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643).
• Expect a difficult block in chronic cannabis users and plan for it: document use, consider technique and post-operative analgesia before starting (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491).
• Avoid selective COX-2 cover peri-operatively where the extraction is routine; the meta-analysis found the excess risk precisely there (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912).
• Use the two adjuncts that have trial-level numbers: chlorhexidine and PRF, and pick them for the high-risk socket rather than as routine theatre habit (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Ávila-Oliver et al., Med Oral Patol Oral Cir Bucal 2025-05-01, PMID 40121674).
• Do not promise a safe hour count: no trial compares abstinence windows, so the advice should be phrased as dose-reduction with the first days as the priority, and the plan written down (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902).
• For implant planning, quote the survival effect rather than refusal: OR 0.40 for implant survival in smokers with follow-up up to 17 years, plus counselling integration (Elena et al., Clin Oral Implants Res 2026-03-01, PMID 41776304).
• Tell vapers what their own saliva does: all vapers had low resting flow in the pilot, and both buffering and pH were worse than non-smokers — a measurable, demonstrable talking point, and a caries-risk argument independent of periodontium (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418).

Evidence at a glance

Question	Estimate as printed	Design and caveat
Does smoking raise post-extraction complications?	Overall complication rate 11.0%; alveolar osteitis 3.4%; persistent pain 4.1%; smoking, uncontrolled diabetes and hypertension the significant patient factors	Retrospective audit, tertiary dental hospital, consecutive extractions (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643)
Is 48 hours evidence-based?	No comparison of abstinence windows exists in the records verified here; the timing guidance is extrapolated from risk data and mechanism	Stated as an absence, not a null result (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902)
Does gauze over the socket make it safe?	Not tested. Documented mechanisms (vasoconstriction, oxygen delivery, fibroblast toxicity, salivary change) are not mechanical	In vitro and cross-sectional mechanism evidence (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527) (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418)
Vaping and the mouth	All vapers had low resting saliva; low buffering 36.8% vs 1.2%; acidic pH 92.9% vs 7.1%; oral bacterial load 5.96 vs 3.70 log₁₀ CFU/mL in cigarette smokers vs non-smokers	Pilot cross-sectional (20 vs 19); comparative cross-sectional (87 men) (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418) (Alghofaili et al., FASEB Bioadv 2026-06-01, PMID 42266505)
Vaping and periodontium	Smokers worse than vapers and non-smokers on GI, PI, PD > 3 mm and CAL; e-cigarette users show worsened periodontal status and poorer treatment response in some studies; microbiota distinct with Veillonella, Leptotrichia, Fusobacterium	SR of 13 studies; narrative review; SR of 12 microbiota studies with very low certainty (Aldalaeen et al., Health Sci Rep 2025-09-01, PMID 40959186) (Robson et al., Br Dent J 2025-11-01, PMID 41315696) (La Rosa et al., J Clin Periodontol 2026-06-01, PMID 41856754)
Nicotine pouches and snus	Oral lesions in 79% of pouch users and 89% of tobacco-pouch users vs non-users; snus: gingival recession, more gingivitis, no periodontitis association, +48% oral clefts with maternal use	Cross-sectional (272 participants); SR of 26 studies (Daneshian et al., Oral Dis 2026-07-01, PMID 42384425) (Bankvall et al., Acta Odontol Scand 2026-02-01, PMID 41649495)
Non-tobacco nicotine and bone	Dose-dependent inhibition of osteoblast proliferation, delayed healing, slowed osseointegration; anti-inflammatory at low doses; no human isolation studies	SR of 62 mostly animal and in vitro studies (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042)
Cannabis and anaesthesia	Hyperalgesia and inadequate block in a chronic user at extraction; for pain, one positive trial of topical CBD in TMD against four nulls; 4 RCTs (3 low RoB) and 9 animal studies (all high RoB)	Case report plus two systematic reviews (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491) (Votrubec et al., Aust Dent J 2022-12-01, PMID 36082517) (Campana et al., Int J Mol Sci 2025-04-01, PMID 40332414)
What reduces the risk	Chlorhexidine 9.58% vs 16.8%; PRF RR 0.33 (0.20 to 0.53, 776 sites); rofecoxib OR 1.89 (1.15 to 3.10); phone follow-up adherence 9.7 vs 7.9	Meta-analysis of 12 studies; SR of 7 RCTs; SR/MA of 32 trials; SR of 10 instruction studies (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Ávila-Oliver et al., Med Oral Patol Oral Cir Bucal 2025-05-01, PMID 40121674) (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912) (Fawzy et al., Clin Cosmet Investig Dent 2026-01-01, PMID 42222518)
Implants and smoking	Implant survival OR 0.40 (95% CI 0.27 to 0.61) in smokers, follow-up 1 to 17 years; counselling recommended rather than exclusion	SR of 45 articles (44 studies) (Elena et al., Clin Oral Implants Res 2026-03-01, PMID 41776304)
Whole-body vaping risk	Heart rate MD 1.41 (0.81 to 2.01; I² = 91%); SBP MD 0.51 (0.26 to 0.75); asthma OR 1.30 (1.1 to 1.55)	Umbrella review of 69 SRs (Kaur et al., BMJ Open 2025-10-01, PMID 41073111)
Secondhand smoke and children’s teeth	In a 672-child survey, passive smoking was associated with higher dft (p = 0.021) unadjusted but not after adjustment; in rats, secondhand exposure widened enamel prism spacing and lowered molar phosphorus (p = 0.033)	Cross-sectional with confounding by socioeconomic factors; animal study (Lam et al., J Dent 2025-10-01, PMID 40639604) (de Lima Gonçalves et al., Calcif Tissue Int 2026-05-01, PMID 42101651)

What the evidence does not support

• A safe number of hours. No verified trial compares abstinence windows after extraction, so any specific figure presented as evidence-based is a convention — the defensible statement is that risk is dose-dependent and the earliest days carry the most (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902).
• That covering the socket makes smoking safe. The mechanism set — perfusion, oxygen carriage, fibroblast toxicity, saliva — is not addressed by a barrier (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527) (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418).
• That vaping is harmless to the mouth or a clean substitute during healing. Periodontal, salivary and microbiota signals are consistent in direction and weak in certainty; the youth scoping review found associations with caries, dry mouth and lesions, and low knowledge of them (Aldalaeen et al., Health Sci Rep 2025-09-01, PMID 40959186) (La Rosa et al., J Clin Periodontol 2026-06-01, PMID 41856754) (Tran et al., Int J Paediatr Dent 2026-07-01, PMID 41992606).
• That nicotine pouches are a safe peri-operative choice. Lesions in 79% of users, and nicotine’s own dose-dependent effect on bone in vitro and in animals, plus the absence of human isolation studies, mean the peri-operative answer is that the local high-concentration route is the worst one (Daneshian et al., Oral Dis 2026-07-01, PMID 42384425) (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042).
• That cannabinoids treat dental pain. Two reviews of this literature converge on insufficiency: one positive study against four nulls, and four trials against nine high-risk animal studies (Votrubec et al., Aust Dent J 2022-12-01, PMID 36082517) (Campana et al., Int J Mol Sci 2025-04-01, PMID 40332414).
• That the facial-plastic-surgery multipliers apply to your socket. 1.8- to 12-fold complications after facial procedures and the seroma risk in reconstruction are not extractions and must not be quoted as if they were (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902) (Tanas et al., Plast Reconstr Surg Glob Open 2026-05-01, PMID 42145836).
• That hookah or heated sticks are excluded from the advice because they feel cleaner. Combustion products, heat and nicotine still traverse the wound site, and hookah users showed disrupted oral microbial balance (Alghofaili et al., FASEB Bioadv 2026-06-01, PMID 42266505).

Cost, coverage and the Utah part

Utah’s published children’s dental benefit summary contains no line for tobacco or nicotine products, no cessation-counselling benefit and no implant line: the words do not appear in the document, which instead sets out the surgical rules that matter in the days after an extraction. Simple extractions are covered without prior authorisation and the benefit text notes the service includes routine removal, the numbing of the area and any necessary stitches; surgical extractions, defined as cases needing bone removal or tooth sectioning, likewise require no prior authorisation; both are covered when a tooth cannot be saved by a filling or a root canal; wisdom tooth removal is covered only when the teeth are impacted or causing pain; emergency treatment of an abscess or acute infection (exam, diagnostic x-rays, incision and drainage) requires no authorisation; and inpatient hospital costs are billed to the medical plan, while general anaesthesia and intravenous sedation are covered only where a child cannot be treated safely under local anaesthesia because of disability or another complex medical condition, with documentation. Nitrous oxide analgesia is explicitly a non-covered service (data as of 4 February 2026; see Additional documents).

Practically, three consequences follow for a family. A complication that could have been avoided by the instruction is still paid for as an emergency visit, so the cheap insurance is the timing rule, not the prescription. If a socket infection develops, it is covered at the urgent-care level without paperwork, but the sequelae of repeated complications — the second extraction, the graft, the eventual implant — are not the same conversation: the children’s benefit lists partial dentures one upper and one lower every five years with prior authorisation and generally excludes fixed bridges, and nothing about implants at all. And where sedation is the plan for an anxious adolescent, note that the route Medicaid funds is intramuscular or intraoral injection or, for complex medical cases, monitored anaesthesia in a hospital — the in-chair laughing-gas option that many clinics advertise is not funded, which is worth knowing before it is offered as the default (data as of 4 February 2026).

A plan for the first 72 hours, and days 4 to 7

• Before the appointment: say what you use. Cigarettes, vapes, heated sticks, pouches, snus, waterpipe, cannabis — the anaesthetic and analgesic plan changes with cannabis and the local-tissue plan changes with pouches (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491) (Daneshian et al., Oral Dis 2026-07-01, PMID 42384425).
• First 24 hours: no inhaled nicotine at all. This is the window the audit data and the mechanism literature both single out; the bleeding, the clot and the first granulation tissue all form here (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527).
• Hours 24 to 72: the risk-reduction phase. If you do use something, less, later and not over the socket; keep the chlorhexidine rinse the clinic gave you, and take the analgesic that is not a selective COX-2 inhibitor (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912).
• Days 4 to 7: swap the route, not the dose. For most people a patch or a pouch used away from the surgical site beats a cigarette over it — with the honest caveat that the bone-healing evidence for nicotine itself is animal and in vitro, and human isolation data are absent (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042).
• Ask for the follow-up call. Phone reinforcement measurably improved adherence in the review of instruction methods, and adherence is where these instructions live or die (Fawzy et al., Clin Cosmet Investig Dent 2026-01-01, PMID 42222518).
• Know the failure signs and act on them: pain rising on days 2 to 4, a bad taste or an empty-looking socket, swelling with fever — that is alveolar osteitis or infection and needs the chair, not more analgesia (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739).

Frequently asked questions

Can I smoke 24 hours after extraction? The best verified answer is that at 24 hours the tissue is at its most vulnerable and the audit finds smoking among the significant risk factors for exactly the complications that appear on days 2 to 4; nobody has tested 24 hours as a safe point (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912).

Can I smoke 5 days after extraction, or after the stitches? Day 5 is past the highest-risk window for clot loss, but granulation and early bone organisation are still running, and the animal and in vitro bone data are the reason the recommendation is not “fine on day 5” but “later and less is better, and the first three days matter most” (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042) (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643).

What if I already smoked? Nothing resets to zero and nothing is doomed: stop now, keep the rinse, avoid the socket with any device, do not start selective COX-2 cover, and call if pain escalates on day 2 or 3 (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912) (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643).

Is vaping safer than smoking after extraction? On the periodontal and systemic evidence, likely less harmful than burning; on mouth-specific healing it is still associated with low flow, low buffering, acidity, distinct microbiota and in young people with lesions — and no socket trial exists for either product, so the answer for the wound is: neither is neutral (Aldalaeen et al., Health Sci Rep 2025-09-01, PMID 40959186) (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418) (La Rosa et al., J Clin Periodontol 2026-06-01, PMID 41856754) (Tran et al., Int J Paediatr Dent 2026-07-01, PMID 41992606).

Can I use a nicotine pouch instead? Away from the surgical site, it removes smoke, heat and carbon monoxide from the wound, and the reviews treat pouches as lower-toxicant products than cigarettes (La Rosa et al., Front Oral Health 2026-01-01, PMID 41737135). It does not remove nicotine, which is the substance with dose-dependent bone and fibroblast findings and the reason the peri-operative period is exactly when the “less nicotine” version of the advice matters (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042) (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527).

Does hookah or heated tobacco count? Yes. Hookah users in the comparative study showed disrupted oral microbiota and raised red-cell indices alongside cigarette smokers, and heated products still deliver nicotine and aerosol chemistry to the same mucosa (Alghofaili et al., FASEB Bioadv 2026-06-01, PMID 42266505) (La Rosa et al., J Clin Periodontol 2026-06-01, PMID 41856754).

I only smoke cannabis. Does the rule apply? The inhalation part applies to the wound as much as any smoke, and the specific cannabis issue for your appointment is anaesthesia: the case literature reports inadequate block and increased pain response, so disclosure before the procedure is the single most useful thing you can do (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491) (Bellocchio et al., Int J Mol Sci 2021-08-01, PMID 34361095).

Is secondhand smoke a dental problem for my kids? The child data are honest about their limits: in 672 preschoolers, exposure was associated with higher decay scores before adjustment and not after, and the enamel effects in secondhand-smoke-exposed rats (wider prism spacing, lower molar phosphorus) are animal findings (Lam et al., J Dent 2025-10-01, PMID 40639604) (de Lima Gonçalves et al., Calcif Tissue Int 2026-05-01, PMID 42101651). Household smoke reduction is worth doing on many grounds; as a caries intervention in itself it is unproven.

I’m having an implant. Must I stop completely? The synthesis says: not an absolute contraindication, but a measured survival penalty (OR 0.40, 95% CI 0.27 to 0.61) with cessation counselling recommended inside the treatment plan rather than as a precondition (Elena et al., Clin Oral Implants Res 2026-03-01, PMID 41776304).

Glossary: kitchen words ↔ chart words

What you say at home	What is in the notes	How studies measure it
“can I smoke yet”	Peri-operative nicotine and smoke exposure after extraction	Complication prevalence and risk-factor regression in extraction audits (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643)
“dry socket”	Alveolar osteitis; clot loss with exposed bone, days 2 to 4	Incidence per site; pooled against chlorhexidine and PRF (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Ávila-Oliver et al., Med Oral Patol Oral Cir Bucal 2025-05-01, PMID 40121674)
“I covered it with gauze”	Mechanical barrier; no effect on vasoconstriction or oxygen carriage	Not represented in any verified trial; mechanism studies are in vitro (Kang et al., Anat Cell Biol 2026-06-01, PMID 42124527)
“I just vape”	Electronic nicotine delivery system use	Salivary flow, pH and buffering; microbiota community structure; periodontal indices (Alsenani et al., BMC Oral Health 2025-11-01, PMID 41261418) (La Rosa et al., J Clin Periodontol 2026-06-01, PMID 41856754) (Aldalaeen et al., Health Sci Rep 2025-09-01, PMID 40959186)
“pouch in the lip”	Tobacco-free nicotine pouch; mucosal lesion, erythema	Graded mucosal examination in cross-sectional comparison (Daneshian et al., Oral Dis 2026-07-01, PMID 42384425)
“snus is harmless”	Smokeless tobacco; recession, gingivitis, pregnancy cleft risk	Systematic review of 26 studies (Bankvall et al., Acta Odontol Scand 2026-02-01, PMID 41649495)
“weed before I go under”	Chronic cannabinoid exposure; hyperalgesia, block failure	Case report and systematic reviews of pain trials (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491) (Votrubec et al., Aust Dent J 2022-12-01, PMID 36082517)
“the strong painkillers for wisdom teeth”	Selective COX-2 inhibitor analgesia	Meta-analysis with alveolar osteitis as an adverse outcome (Isiordia-Espinoza et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41578912)
“will the implant fail”	Peri-implant bone and soft-tissue healing in smokers	Survival odds ratio with follow-up to 17 years (Elena et al., Clin Oral Implants Res 2026-03-01, PMID 41776304)
“the rinse they gave me”	Chlorhexidine mouth rinse, local antiseptic protocol	Pooled relative reduction versus control in third-molar surgery (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739)

Related reading on this site: what to do about a toothache at night, what to eat and drink in the first days, which swelling signs mean the emergency department and what the peroxide evidence says about whitening.

How this page was built, and what it cannot tell you

Method: candidate records were located in Europe PMC with queries that mirror real searches (“how long to not smoke after extraction”, “can i vape after tooth extraction”, “nicotine pouches after tooth extraction”, “чи можна курити після видалення зуба”, “cuándo puedo fumar después de una extracción”), and every record used — authors, journal, volume, pages, DOI, PMID, open-access flag, citation count — was re-fetched on the day of publication and is reproduced below with its DOI. Numbers come from the retrieved abstracts; intervals are reproduced as printed; where the abstract is a case report or an animal study, the article says so rather than upgrading it. The figure uses one source reporting one unit. Coverage statements were read from the CMS InsureKidsNow benefit summary for Utah Medicaid (data as of 4 February 2026) and checked against that text, including the negative findings: no cessation-counselling and no implant line exist in that document. The central limitation is structural: this topic is dominated by audits, cross-sectional designs, in vitro work and borrowed surgical data, and the one number patients most want — how many hours — is not in any of it (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643) (Chouksey et al., Arch Craniofac Surg 2026-02-01, PMID 41787902) (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042).

What this page cannot tell you: your personal risk, because the verified evidence does not model dose-times-day-since-surgery interaction, and the audit reports group-level association, not individual prediction (Dignam et al., Aust Dent J 2025-12-01, PMID 40492643). It cannot tell you a safe single cigarette, a safe puff, or a safe day, and it cannot tell you whether pouches delay bone healing in humans, because the isolation studies do not exist (Travis et al., J Orthop Surg Res 2026-03-01, PMID 41782042). What it can do is keep the advice in proportion: the earliest days matter most, inhaled and locally placed nicotine are the modifiable parts, chlorhexidine and PRF and a phone call are the parts with numbers behind them, and disclosure about cannabis changes the anaesthetic plan rather than your eligibility (Bucataru et al., Med Oral Patol Oral Cir Bucal 2026-05-01, PMID 41273739) (Ávila-Oliver et al., Med Oral Patol Oral Cir Bucal 2025-05-01, PMID 40121674) (Fawzy et al., Clin Cosmet Investig Dent 2026-01-01, PMID 42222518) (Hammoud et al., Toxicol Rep 2026-12-01, PMID 42404491).

Sources

Peer-reviewed evidence

• Bellocchio L, Inchingolo AD, Inchingolo AM, Lorusso F, Malcangi G, Santacroce L, Scarano A, Bordea IR, Hazballa D, D’Oria MT, Isacco CG, Nucci L, Serpico R, Tartaglia GM, Giovanniello D, Contaldo M, Farronato M, Dipalma G, Inchingolo F. Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review. Int J Mol Sci 2021-08-01;22(15):8329. doi:10.3390/ijms22158329 · PMID 34361095 · PMCID PMC8347083 · open access · cited by 30 (Europe PMC)
• Votrubec C, Tran P, Lei A, Brunet Z, Bean L, Olsen BW, Sharma D. Cannabinoid therapeutics in orofacial pain management: a systematic review. Aust Dent J 2022-12-01;67(4):314-327. doi:10.1111/adj.12934 · PMID 36082517 · PMCID PMC10087667 · open access · cited by 13 (Europe PMC)
• Ávila-Oliver C, Veloso V, Laissle G, Rojas AM, Verdugo-Paiva F, Ramos-Rojas J. Efficacy of platelet-rich-fibrin for the treatment of alveolar osteitis: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2025-05-01;30(3):e345-e353. doi:10.4317/medoral.26801 · PMID 40121674 · PMCID PMC12019651 · open access · cited by 1 (Europe PMC)
• Campana MD, de Paolis G, Sammartino G, Bucci P, Aliberti A, Gasparro R. Cannabinoids: Therapeutic Perspectives for Management of Orofacial Pain, Oral Inflammation and Bone Healing-A Systematic Review. Int J Mol Sci 2025-04-01;26(8):3766. doi:10.3390/ijms26083766 · PMID 40332414 · PMCID PMC12028210 · open access · cited by 6 (Europe PMC)
• Dignam P, Elshafey M, Jeganathan A, Foo M, Park JS, Ratnaweera M. Prevalence and Risk Factors of Post-Extraction Complications in a Western Australian Tertiary Dental Hospital: A Retrospective Cross-Sectional Study. Aust Dent J 2025-12-01;70(4):266-274. doi:10.1111/adj.13082 · PMID 40492643 · PMCID PMC12661133 · open access · cited by 1 (Europe PMC)
• Lam PPY, Guo K, Chan SSC, Lo ECM, Yiu CKY. Analysis of prenatal and passive smoking exposure and Early Childhood Caries among preschool children in Hong Kong. A cross-sectional study. J Dent 2025-10-01;161():105967. doi:10.1016/j.jdent.2025.105967 · PMID 40639604 · cited by 1 (Europe PMC)
• Aldalaeen MO, Haddad RH, Alhusamiah BK, Abuejheisheh AJ. The Impact of Cigarette Smoking and Vaping Use on the Development and Progression of Periodontitis: A Systematic Review. Health Sci Rep 2025-09-01;8(9):e71245. doi:10.1002/hsr2.71245 · PMID 40959186 · PMCID PMC12434186 · open access · cited by 4 (Europe PMC)
• Kaur J, Goel S, Shabil M, Rana RK, Rinkoo AV, Chauhan A, Gupta S. Health impacts of electronic nicotine delivery systems: an umbrella review of systematic reviews. BMJ Open 2025-10-01;15(10):e100168. doi:10.1136/bmjopen-2025-100168 · PMID 41073111 · PMCID PMC12516984 · open access · cited by 9 (Europe PMC)
• Alsenani M, Alothman L, Alsenaidi J, Alnowaiser A, Aldawsari M, Alharbi N. Correlation between e-cigarette use and salivary flow rate, pH, and buffering capacity: a cross-sectional pilot study. BMC Oral Health 2025-11-01;25(1):1806. doi:10.1186/s12903-025-07255-w · PMID 41261418 · PMCID PMC12632013 · open access
• Bucataru E, Romero-Olid MD, Ramos-García P, González-Moles MÁ. Clinical applications of chlorhexidine in oral wound healing: Scoping review of current evidence and research gaps. Med Oral Patol Oral Cir Bucal 2026-05-01;31(3):e399-e407. doi:10.4317/medoral.27864 · PMID 41273739 · PMCID PMC13135296 · open access
• Robson G, Lim XC, Chaudhari I, Hurley J, Khalil S, Amin V, Nibali L. Trying to clear the air: e-cigarette use and periodontal disease. Br Dent J 2025-11-01;239(10):687-692. doi:10.1038/s41415-025-8919-5 · PMID 41315696 · PMCID PMC12662773 · open access · cited by 1 (Europe PMC)
• Aldulaijan HA, Alayadi H, Talakey AA, Alkurdi RB, Shaheen MY. Effect of a Topical Oxygen-Releasing Gel on Osseous-Augmentation Following Socket Preservation in a Male Smoker With Type-2 Diabetes Mellitus: A Case Report. J Oral Implantol 2025-12-01;51(6):500-505. doi:10.1563/aaid-joi-d-25-00121 · PMID 41365335
• Isiordia-Espinoza MA, Hernández-Gómez A, Bologna-Molina R, Serafín-Higuera N, Molina-Frechero N, Gómez-Sánchez E, López-Verdín S, Guzmán-Flores JM. Cyclooxygenase-2 selective inhibitors increase the risk of alveolar osteitis: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2026-05-01;31(3):e363-e370. doi:10.4317/medoral.27577 · PMID 41578912 · PMCID PMC13135291 · open access
• Bankvall M, Jontell M. Swedish smokeless tobacco and its impact on oral health: a systematic review. Acta Odontol Scand 2026-02-01;85():84-95. doi:10.2340/aos.v85.45421 · PMID 41649495 · PMCID PMC12892112 · open access
• La Rosa GRM, Samaranayake LP, Zaura E, Chapple I, Polosa R. Nicotine pouches, oral cancer and tobacco harm reduction: current evidence and research priorities. Front Oral Health 2026-01-01;7():1761734. doi:10.3389/froh.2026.1761734 · PMID 41737135 · PMCID PMC12926464 · open access
• Elena C, Stefano C, Marina D, Pinar E, Nikolaos D. Tobacco Smoking and Smoke-Free Products as Risk Factors for Dental Implants: A Systematic Review. Clin Oral Implants Res 2026-03-01;37(3):262-286. doi:10.1111/clr.70108 · PMID 41776304 · PMCID PMC12975700 · open access · cited by 2 (Europe PMC)
• Travis LM, Cacciatore JC, Schuster JA, Khan F, Stern JM, Moore MR, Hneiny L, Hernandez VH, McNamara CA. The effect of non-tobacco nicotine on bone healing: a systematic review and application to total joint arthroplasty. J Orthop Surg Res 2026-03-01;21(1):253. doi:10.1186/s13018-026-06733-3 · PMID 41782042 · PMCID PMC13067556 · open access · cited by 1 (Europe PMC)
• Chouksey G, Agrawal A, Bhargava S, Karna ST. Review on the impact of smoking on wound healing following facial procedures. Arch Craniofac Surg 2026-02-01;27(1):1-9. doi:10.7181/acfs.2025.0102 · PMID 41787902 · PMCID PMC12968644 · open access
• La Rosa GRM, Samaranayake LP, Zaura E, Sun A, Fuochi V, Furneri PM, Kowalski J, Myszel K, Chapple I, Polosa R. Impact of Electronic Cigarette Use on the Oral Microbiota: A Systematic Review. J Clin Periodontol 2026-06-01;53(6):956-985. doi:10.1111/jcpe.70111 · PMID 41856754 · PMCID PMC13167625 · open access
• Kumar PS, Beverly ML, Galindo-Fernandez P, Thompson W, Verma M, Shick E. To Vape or Not to Vape: Oral Health in the Age of Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems. Int Dent J 2026-06-01;76(3):109523. doi:10.1016/j.identj.2026.109523 · PMID 41932095 · PMCID PMC13085071 · open access · cited by 1 (Europe PMC)
• Tran J, Bendotti H, Vandeleur M. Associations Between Oral Health Related Outcomes and Electronic Cigarette Use in Young People: A Scoping Review. Int J Paediatr Dent 2026-07-01;36(4):577-584. doi:10.1111/ipd.70090 · PMID 41992606 · PMCID PMC13278668 · open access · cited by 1 (Europe PMC)
• de Lima Gonçalves J, Silva-Sousa AC, de Sousa-Neto MD, de Carvalho FK, de Queiroz AM, Ganss B, de Paula-Silva FWG. Impact of Secondhand Smoke on the Biomineralization of Dental Enamel in Rats. Calcif Tissue Int 2026-05-01;117(1):79. doi:10.1007/s00223-026-01542-6 · PMID 42101651 · PMCID PMC13156134 · open access
• Kang M, Lee J, Wang YH, Huh W, Chung S, Kim L, Zarembo VR, Yim H, Lin HYA, Wang Y, Robles AJ, Yoo J. Vape flavoring chemicals and oral fibroblast viability. Anat Cell Biol 2026-06-01;59(2):247-255. doi:10.5115/acb.26.047 · PMID 42124527 · PMCID PMC13291692 · open access
• Tanas Y, Harris P, Chen S, Heckel B, Nguyen P, Wang J, Gasper G, Swed S, Spiegel A. A Global Propensity Score-matched Analysis of 56,992 Nicotine-dependent Versus Nondependent Breast Reconstruction Cases. Plast Reconstr Surg Glob Open 2026-05-01;14(5):e7725. doi:10.1097/gox.0000000000007725 · PMID 42145836 · PMCID PMC13179029 · open access
• Fawzy AK, Soliman AH, Hussein MF, Hassan WY, Mohamed MM, Soliman HMH. Impact of Postoperative Instruction Delivery Methods on Patient Compliance After Minor Oral Surgeries: A Systematic Review. Clin Cosmet Investig Dent 2026-01-01;18():616315. doi:10.2147/ccide.s616315 · PMID 42222518 · PMCID PMC13222047 · open access
• Alghofaili F, Hussein HM, Najmuldeen HHR, Tahsin SY, Muhamad AH, Othman AJ, Karim KF, Ali AO, Karim AS. Comparative Effects of Cigarette and Hookah Smoking on Oral Microbiota Composition and Blood Indices in Young Adult Males. FASEB Bioadv 2026-06-01;8(6):e70119. doi:10.1096/fba.2025-00296 · PMID 42266505 · PMCID PMC13244071 · open access
• Daneshian M, Fredriksson L, Skott P, Garming Legert K. Oral Lesions and Dental Status in Individuals Using Oral Tobacco-Free Nicotine Pouches. Oral Dis 2026-07-01;. doi:10.1111/odi.70409 · PMID 42384425
• Hammoud S, Magno MHI, Akhikar J, Filho LCM. Cannabis-associated hyperalgesia and reduced local anesthetic efficacy in oral surgery: A case report. Toxicol Rep 2026-12-01;17():102300. doi:10.1016/j.toxrep.2026.102300 · PMID 42404491 · PMCID PMC13330503 · open access

Additional documents

• InsureKidsNow (CMS). Summary of Benefits Report for Utah, Medicaid — dental (data as of 04 Feb 2026, print date 03/02/2026) — the children’s dental benefit contains no line about tobacco or nicotine products and no smoking-cessation counselling benefit: those words do not appear in the document. What it does set out are the surgical rules that govern the days after an extraction: simple extractions covered without prior authorisation, the service including routine removal, the numbing of the area and any necessary stitches; surgical extractions, defined as cases requiring bone removal or tooth sectioning, also without prior authorisation; both covered when a tooth cannot be saved by a filling or a root canal; wisdom tooth removal covered only when the tooth is impacted or causing pain; and emergency treatment of an abscess or acute infection (exam, diagnostic x-rays, incision and drainage) with no prior authorisation (PDF)
• InsureKidsNow (CMS), same report — the lines that decide what a smoker can actually be offered: inpatient hospital services are not covered by the dental plan, with hospital-related costs such as the facility fee and room billed to the medical plan for dental procedures performed in an inpatient setting; general anaesthesia and intravenous conscious sedation are covered only when medically necessary for children who cannot be treated safely under local anaesthesia because of physical or mental disability or another complex medical condition, with documentation maintained in the record; non-intravenous conscious sedation is covered only as intramuscular or intraoral injection; behaviour management is not covered and orally administered sedation medications go through the Medicaid pharmacy benefit by prescription only; nitrous oxide analgesia is a non-covered service under the dental plan (PDF)

Bibliographic records above were retrieved and verified programmatically from Europe PMC (authors, journal, volume, pages, DOI, PMID, citation count). Coverage, guideline and regulatory statements are quoted from the cited public documents with their dates; verify against the current version before relying on them. This article is not medical or dental advice.